Filing Details
- Accession Number:
- 0001144204-15-010774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 21:51:03
- Reporting Period:
- 2014-01-29
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 21:51:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Biosciences Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1315082 | Ra Capital Healthcare Fund Lp | C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | No | Yes | |
| 1346824 | Ra Capital Management, Llc | 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | No | Yes | |
| 1384859 | Peter Kolchinsky | C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-03-06 | 40,482 | $24.10 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-06 | 21,001 | $24.10 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-07 | 258,377 | $22.25 | 3,683,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-10 | 12,522 | $22.30 | 3,683,000 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2014-03-12 | 123,480 | $23.40 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-13 | 71,319 | $22.76 | 3,683,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-17 | 52,161 | $23.02 | 3,683,000 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2014-03-18 | 34,440 | $23.74 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-18 | 49,560 | $23.75 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-19 | 17,808 | $24.28 | 3,683,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-21 | 101,808 | $21.22 | 3,683,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-25 | 21,000 | $19.33 | 3,704,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-25 | 42,000 | $19.44 | 3,746,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-25 | 21,000 | $19.46 | 3,767,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-26 | 19,320 | $17.88 | 3,786,320 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-26 | 190,693 | $18.16 | 3,977,013 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-27 | 4,200 | $17.35 | 3,981,213 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-27 | 251,987 | $17.66 | 4,233,200 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-28 | 21,840 | $17.07 | 4,255,040 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-03-28 | 62,160 | $17.11 | 4,317,200 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2014-04-01 | 48,500 | $17.88 | 4,268,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-01 | 24,900 | $17.89 | 4,243,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-01 | 50,000 | $17.95 | 4,193,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-01 | 51,500 | $18.08 | 4,142,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-01 | 75,100 | $18.14 | 4,067,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Col 5 of Table I and the number of options reported in Col 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the time of the last transaction reported herein.
- The Fund delivered these shares to a stock lender to satisfy the Fund's obligation to return shares previously borrowed.
- The Fund borrowed shares for delivery against this sale.
Billionaire Hedge Funds
